Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June
Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming investor conferences in June.
Read More
Category: US Stocks
WeedMD to Convert Aylmer Facility to Cannabis Extraction and Processing Hub
WeedMD Inc. is transitioning the Aylmer site to produce a wide range of extracts and concentrates.
Read More
Cara Therapeutics Announces Positive Results From KALM-1 Pivotal Phase 3 Trial of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
CARA looks forward to reporting topline data from our second global Phase 3 trial, KALM-2, in the second half of this year.
Read More
Zynerba Pharmaceuticals Announces Initiation of Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome
The INSPIRE trial will assess the safety, tolerability and efficacy of Zygel (ZYN002 CBD gel) for the treatment of behavioral symptoms of 22q11.2 Deletion Syndrome (22q).
Read More
HEXO Corp. announces acquisition of Securities of Newstrike Brands Ltd.
HEXO acquired all of the issued and outstanding common shares of Newstrike by way of a plan of arrangement under the Business Corporations Act (Ontario).
Read MoreGET LISTED
